Healthcare / Medical Care FacilitiesNasdaqCM
$0.59
-0.00 (-0.67%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 20%
FCF escenarios
weak_data · normalized FCF $2.5M · quality 45.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
19/100
F
Piotroski
1/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$11M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-195.7%
↓Gross Margin
77.5%
↑Debt/Equity
0.93
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+2.0%
FCF CAGR
—
FCF margin
-32.0%
FCF / Net income
0.34x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $11.3M · net income $-10.6M · FCF $-3.6M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $11.3M | $11.3M | $10.1M | $9.7M | $10.7M |
| Net Income | $-10.6M | $-10.6M | $2.1M | $1.8M | $2.0M |
| EBITDA | $-9.7M | $-9.7M | $3.1M | $2.9M | $3.3M |
| EPS | — | — | 0.11 | 0.10 | 0.12 |
| Gross Margin | 77.5% | 77.5% | 77.6% | 75.9% | 79.6% |
| Operating Margin | -19.2% | -19.2% | 21.8% | 21.4% | 23.2% |
| Net Margin | -94.0% | -94.0% | 20.6% | 18.4% | 18.6% |
| Balance Sheet | |||||
| Debt/Equity | 0.93 | 0.93 | 0.57 | 1.31 | 2.74 |
| Current Ratio | 1.31 | 1.31 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-3.6M | $-3.6M | $2.5M | $2.6M | $2.7M |
| Returns | |||||
| ROE | -195.7% | -195.7% | 27.4% | 32.5% | 53.4% |
| Valuation | |||||
| P/B | 2.04 | 2.04 | — | — | — |
| Growth & Yield | |||||
| Revenue Growth | 12.6% | 12.6% | 3.6% | -9.0% | — |
| EPS Growth | — | — | 16.2% | -20.6% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-90.3%
Start / end P/E
n/dx → n/dx
EPS bridge
0.11 → n/d
Residual
-90.3%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.